Novo Gets Approval to Sell Wegovy Obesity Pill in the US

Novo Nordisk US listed shares jumping in late trading after it secured FDA approval for a pill version of its weight loss. Jab Wegovy. The pill is expected to launch in the US in January.Let's get more from Bloomberg's pharma reporter, Amber Tong. Amber. Walk us through the significance of this.We've had, of course, the injection for quite some time. Why is a pill so important. Yeah.Oliver, This is really something that many people have been waiting for for a long time. As you said, Wegovy and Novo Nordisk ...